文献库搜索 | GeneLibs

Stracke(C),Kautz-Freimuth(S),Shukri(A),Iss... PLoS One None

Women with BRCA1/2 pathogenic variants (PVs) without a personal cancer history and with open family planning are in a ve...

Xu(Y),Lei(Q),Yang(S),Zhang(Y),Luo(X),Song(... Eur J Med Chem 2026-08-16

...BRCA1, BRCA2 and RAD51, thereby triggering enhanced DNA damage and cell apoptosis. Notably, in the BRCA wild-type MDA-MB...

Zhu(H),Fang(Y),Yang(M),Gao(T),Zhou(Y),Zhao... Transl Oncol 2026-08-17

...BRCA1 was selected for functional validation. Consistent with the bioinformatic analyses, BRCA1 was markedly upregulated...

Incorvaia(L),Santini(D),Matrana(MR),Maruzz... Int J Cancer 2026-08-18

...BRCA1/2 vs. non-BRCA HRR: 16.3 months [95% CI, 13.0-69.6] vs. 14.2 [95% CI, 12.0-22.9; p = 0.681]). Primary refractorine...

Reinert(T),Alshehri(AS),Shafik(A),Lin(CH),... Ther Adv Med Oncol None

...BRCA1/2 or PALB2 testing, while ctDNA is preferred for ESR1 detection. Next-generation sequencing (NGS) is the preferred...

Ruci(A),Smart(C) Cureus 2026-07-00

...BRCA1)/ataxia-telangiectasia mutated (ATM) mutations and invasive lobular carcinoma of the left breast status post bilat...

Akahori(T),Yokotani(T),Yoshizawa(A),Uchiya... Surg Case Rep None

...BRCA1 pathogenic variant. Maintenance olaparib was subsequently introduced, resulting in durable disease stabilization a...

Taki(AG),Shareef(A),Arora(V),Oweis(R),Jyot... Iran J Basic Med Sci None

...BRCA1-deficient tumors. Adaptive AI pipelines that iteratively refine guide RNAs and exosome-mimetic carriers, incorpora...

Nahshon(C),Fahoum(L),Hadar(D),Cohen(H),Mic... Breast Cancer 2026-08-18

Women with BRCA1/2 pathogenic variants face increased risks of breast and ovarian cancers. Our study aimed to evaluate t...

Song(H),Jia(Y),Qiu(X),Long(T),Yang(W) Front Pharmacol None

...BRCA1, SERPINA1, and LGALS3. Molecular docking confirmed stable binding of Galanin to the proteins encoded by these gene...